-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Buy on Sana Biotechnology, Lowers Price Target to $6

Benzinga·08/14/2026 18:19:19
Listen to the news
B of A Securities analyst Alex Stranahan maintains Sana Biotechnology (NASDAQ:SANA) with a Buy and lowers the price target from $7 to $6.